Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €56.70 EUR
Change Today -0.212 / -0.37%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:10 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alkermes plc (8AK)

Currency in
Millions of US Dollars
As of:Mar 31
2011
Reclassified
Mar 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
NET INCOME-45.5-113.720.6-30.1
Depreciation & Amortization8.722.534.939.9
Amortization of Goodwill and Intangible Assets--25.448.858.2
DEPRECIATION & AMORTIZATION, TOTAL8.747.983.798.1
(Gain) Loss from Sale of Asset----0.1-40.1
(Gain) Loss on Sale of Investment-------44.9
Asset Writedown & Restructuring Costs--45.88.7--
Other Operating Activities-3.9-10.2-17.2-10.0
Tax Benefit from Stock Options---4.3-15.9-32.4
Change in Accounts Receivable2.3-14.0-14.3-17.4
Change in Inventories5.2-4.9-5.2-31.2
Change in Accounts Payable7.015.642.756.9
Change in Unearned Revenues0.66.13.2-1.0
Change in Other Working Capital-0.10.5-0.33.6
CASH FROM OPERATIONS-5.9-2.5147.511.1
Capital Expenditure-9.4-17.0-27.3-33.7
Sale of Property, Plant, and Equipment0.40.00.244.4
Cash Acquisitions---494.8----
Investments in Marketable & Equity Securities14.694.6-150.1-274.1
CASH FROM INVESTING5.6-417.2-177.2-263.4
Long-Term Debt Issued--444.1----
TOTAL DEBT ISSUED--444.1----
Long Term Debt Repaid-45.4-0.8---6.7
TOTAL DEBT REPAID-45.4-0.8-8.8-6.7
Issuance of Common Stock6.220.965.9296.0
Other Financing Activities-1.40.74.219.5
CASH FROM FINANCING-40.7464.861.3308.8
NET CHANGE IN CASH-40.945.231.756.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €56.70 EUR -0.212

8AK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cosmo Pharmaceuticals SA SFr.167.80 CHF 0.00
Emergent BioSolutions Inc $32.85 USD +0.49
Impax Laboratories Inc $47.77 USD +1.46
Jazz Pharmaceuticals PLC $178.01 USD +0.64
Pacira Pharmaceuticals Inc/DE $69.31 USD -0.23
View Industry Companies
 

Industry Analysis

8AK

Industry Average

Valuation 8AK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.4x
Price/Book 6.6x
Price/Cash Flow 383.7x
TEV/Sales 12.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.